Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitramyn is a comprehensive multivitamin and multimineral supplement marketed by Puretek Corporation under the DermacinRx brand. It is formulated to provide essential micronutrients that serve as cofactors for a wide range of physiological processes, including energy metabolism, DNA synthesis, and antioxidant defense. The product contains a broad spectrum of vitamins, including Vitamin A, Vitamin C, Vitamin D3, Vitamin E, and the B-complex (thiamine, riboflavin, niacin, B6, folate, B12, biotin, and pantothenic acid), alongside essential minerals such as calcium, iron, magnesium, zinc, and selenium. Vitramyn is typically used to treat or prevent nutritional deficiencies and is often included as adjunctive therapy in clinical kits for conditions such as wound care, pain management, and migraine support to optimize patient recovery and general wellness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitramyn.